Home

Lote 1 - BEVACIzumab 100MG

Tender information

TED EU

Lisboa, Portugal

Type
29
Procedure
open
Ref. number
482465-2026
Estimated value
71,125 EUR
CPV
33651500

C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )

Show all tender information

Documents

Show all important dates